|
Overexpression of P53 protein and local hGH, IGF-I, IGFBP-3, IGFBP-2 and PRL secretion by human breast cancer explants
|
02 March 2014 |
|
Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor
|
25 February 2014 |
|
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland
|
25 February 2014 |
|
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells
|
20 February 2014 |
|
New concepts in prolactin biology
|
20 February 2014 |
|
Somatostatin in breast cancer
|
19 February 2014 |
|
Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells
|
19 February 2014 |
|
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124]
|
19 February 2014 |
|
Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma
|
12 February 2014 |
|
Molecular mechanisms of somatostatin receptor trafficking
|
10 February 2014 |